![](/img/cover-not-exists.png)
Significant Improvement in Quality of Life (QoL) in Patients With Chronic Myeloproliferative Neoplasms (CMPN) and Myelofibrosis Treated With JAK-1 and JAK-2 Inhibitor Ruxolitinib
Vargas-Viveros, Pablo, Hurtado-Monroy, Rafael, Candelaria-Hernández, MyrnaVolume:
14
Language:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2014.06.099
Date:
September, 2014
File:
PDF, 224 KB
english, 2014